Christopher Sayed, MD, discusses how hidradenitis suppurativa typically presents and looks forward, following the November approval of bimekizumab.
Treatment should focus on the underlying causes of borderline personality disorder – trauma – rather stigmatise the person.
In an American Academy of Pediatrics clinical report published online Jan. 21 in Pediatrics, guidance is presented for the ...